← REGULATORY CHANGES
FEDERAL REGISTER · NOTICEJune 26, 2024NOTICE — NO LEGAL EFFECT

Food and Drug Administration Information Technology Strategy and Customer Experience Strategy; Request for Comments

What this record is not

Document details are published in the U.S. Federal Register; SPEQ surfaces them for reference and is not affiliated with or endorsed by the FDA or the Office of the Federal Register. The authoritative text is on federalregister.gov.

STATUSNOTICE — NO LEGAL EFFECT
EFFECTIVE—
COMMENTS CLOSEJul 31, 2024 · closed
APPLIES TO · SPEQ TAGNot tagged
Document type
Notice
Agency
Health and Human Services Department
Published
June 26, 2024
Comments close
July 31, 2024
Document number
2024-13941
Docket
FDA-2024-N-2886
ABSTRACT

The Food and Drug Administration (FDA or Agency) is requesting comments on its "Information Technology (IT) Strategy" and "Customer Experience (CX) Strategy." In accordance with the Agency's User Fee Program commitments and Omnibus Bill requirements, FDA must annually update and publish its IT Strategy by September 30. The initial strategy, released in September 2023, outlines the future direction of FDA's data and technology capabilities. A key objective of FDA's IT Strategy is to modernize enterprise services and capabilities to improve customer experience. The FDA CX Strategy was created to guide this effort. This comprehensive enterprise plan introduces the Agency's CX framework and considers the perspective of interested parties such as the public, employees, and industry.

Abstract as published in the Federal Register.

READ THE FULL DOCUMENT

The complete document — every provision, the docket, and the comment instructions — is published in the Federal Register. SPEQ surfaces and indexes it for reference; the authoritative text lives on federalregister.gov.

View on federalregister.gov →

That is what FDA published. A free account files it on your watchlist and sends one weekly email with whatever lands next.

Create a free account